当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析

浙江医药

(600216)

  

流通市值:138.33亿  总市值:139.82亿
流通股本:9.51亿   总股本:9.62亿

浙江医药(600216)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.58亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1136512.22万元,未分配利润665072.89万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1417850.75万元,负债281338.52万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,190,864,565.878,880,602,021.786,695,297,924.394,322,874,759.83
营业总成本1,909,389,936.377,817,212,979.345,638,082,321.043,511,652,540.63
其他经营收益
营业利润306,353,983.53962,930,093.231,048,294,343.4761,999,585.03
利润总额306,451,485.43951,729,488.241,046,306,587.3758,881,420.16
净利润258,361,542.94760,239,195866,731,612.94624,571,156.24
每股收益
其他综合收益-8,374,276.0617,625,973.2823,198,143.3528,286,096.28
综合收益总额249,987,266.88777,865,168.28889,929,756.29652,857,252.52
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计7,152,920,832.957,211,294,695.177,121,017,781.087,114,739,673.49
非流动资产:
非流动资产合计7,025,586,620.566,879,392,675.797,014,510,876.687,087,169,849.01
资产总计14,178,507,453.5114,090,687,370.9614,135,528,657.7614,201,909,522.5
流动负债:
流动负债合计2,111,369,220.332,439,799,386.792,553,967,626.422,384,856,722.85
非流动负债:
非流动负债合计702,016,009.68561,821,059.67370,484,655.66427,057,436.43
负债合计2,813,385,230.013,001,620,446.462,924,452,282.082,811,914,159.28
所有者权益(或股东权益):
归属于母公司股东权益合计11,240,627,358.7410,943,373,741.0311,054,845,999.6711,214,681,567.51
股东权益合计11,365,122,223.511,089,066,924.511,211,076,375.6811,389,995,363.22
负债和股东权益合计14,178,507,453.5114,090,687,370.9614,135,528,657.7614,201,909,522.5
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,209,582,997.759,557,435,816.717,517,127,199.14,933,125,935.97
经营活动现金流出小计2,109,567,191.257,671,667,105.446,028,461,425.194,134,944,730.93
经营活动产生的现金流量净额100,015,806.51,885,768,711.271,488,665,773.91798,181,205.04
投资活动产生的现金流量:
投资活动现金流入小计507,067,300.432,118,092,288.331,521,591,183.19909,447,045.65
投资活动现金流出小计893,583,041.52,490,039,102.611,764,620,085.631,036,475,006.73
投资活动产生的现金流量净额-386,515,741.07-371,946,814.28-243,028,902.44-127,027,961.08
筹资活动产生的现金流量:
筹资活动现金流入小计341,100,000769,781,200546,577,625.82495,000,000
筹资活动现金流出小计213,763,445.881,172,643,856.84914,225,923.19486,767,481.42
筹资活动产生的现金流量净额127,336,554.12-402,862,656.84-367,648,297.378,232,518.58
汇率变动对现金及现金等价物的影响-30,817,344.9290,287,386.8855,426,355.6863,636,449.18
现金及现金等价物净增加额-189,980,725.371,201,246,627.03933,414,929.78743,022,211.72
期末现金及现金等价物余额2,976,851,312.723,166,832,038.092,899,000,340.842,708,607,622.78
补充资料:
现金及现金等价物的净增加额-1,201,246,627.03-743,022,211.72
最新报告期:2026-04-23
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城证券王彤,肖亚平1.201.341.522026-04-23
中金公司侯一林,裘孝锋,贾雄伟1.151.25--2026-04-13
TOP↑